| Stage | AVNT | % of rev | DORM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $891M | 100.00% | $562M | 100.00% | AVNT ×1.59 |
| Gross profit | $272M | 30.50% | $222M | 39.45% | DORM +9.0pp |
| Operating income | $83M | 9.27% | $83M | 14.76% | DORM +5.5pp |
| Pre-tax income | $59M | 6.56% | $77M | 13.77% | DORM +7.2pp |
| Net income | $44M | 4.88% | $59M | 10.53% | DORM +5.7pp |
| Stage | AVNT | DORM | Gap · A − B |
|---|---|---|---|
| Revenue | $891M100.00% | $562M100.00% | AVNT ×1.59 |
| Gross profit | 30.50%$272M | 39.45%$222M | DORM +9.0pp |
| Operating income | 9.27%$83M | 14.76%$83M | DORM +5.5pp |
| Pre-tax income | 6.56%$59M | 13.77%$77M | DORM +7.2pp |
| Net income |
| 4.88%$44M |
| 10.53%$59M |
| DORM +5.7pp |
No disclosed counterparties: AVNT, DORM.